Jefferies upgraded Ingevity from Hold to Buy and set a new price target of $62.00 from $52.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/26/2025 | $62.00 → $65.00 | Market Perform → Outperform | BMO Capital Markets |
| 8/7/2024 | $58.00 | Market Perform → Market Outperform | CJS Securities |
| 4/22/2024 | $52.00 → $62.00 | Hold → Buy | Jefferies |
| 11/6/2023 | $49.00 | Market Outperform → Market Perform | CJS Securities |
| 10/3/2023 | $62.00 → $53.00 | Buy → Hold | Loop Capital |
| 8/7/2023 | $71.00 → $60.00 | Outperform → Market Perform | BMO Capital Markets |
| 7/27/2023 | $64.00 → $75.00 | Hold → Buy | Loop Capital |
| 5/5/2023 | $92.00 → $64.00 | Buy → Hold | Loop Capital |
S-8 - Ingevity Corp (0001653477) (Filer)
S-8 POS - Ingevity Corp (0001653477) (Filer)
10-Q - Ingevity Corp (0001653477) (Filer)
HIGHLIGHTS: Net sales of $284.0 million, down 17% compared to prior year, primarily due to repositioning actions in Performance Chemicals, which included the exit of certain lower-margin end markets Net income of $20.5 million and diluted earnings per share (EPS) of $0.56 reflects before-tax special charges of $20.2 million; adjusted earnings of $36.4 million and diluted adjusted EPS of $0.99 Adjusted EBITDA of $91.3 million increased 23% and adjusted EBITDA margin improved to 32.1% due primarily to the successful execution of repositioning actions in Performance Chemicals and continued strong profitability in Performance Materials Operating cash flow of $25.4 million with free cash
Ingevity Corporation (NYSE:NGVT) announced today that it will release its first-quarter 2025 earnings after the stock market close on Monday, May 5, 2025. The company will host a live webcast on Tuesday, May 6, at 9:00 a.m. (Eastern) to discuss first-quarter 2025 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 815699. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on May 6, 2025, through M
Board and Management Team Have Taken Significant and Decisive Action to Respond to External Market Challenges Key Transformational Changes Are Driving Strong Financial Results and Stock Price Outperformance Continued Execution of Proven Strategy Positions Ingevity to Unlock Significant Additional Stockholder Value Company Urges Stockholders to Vote "FOR" ONLY Ingevity's Highly Qualified Director Nominees on the WHITE Proxy Card Launches VoteIngevity.com Providing Additional information for Stockholders Ingevity Corporation (NYSE:NGVT) today announced that it has filed its definitive proxy statement with the U.S. Securities and Exchange Commission in connection with its 2025 Annual Meet
BMO Capital Markets upgraded Ingevity from Market Perform to Outperform and set a new price target of $65.00 from $62.00 previously
CJS Securities upgraded Ingevity from Market Perform to Market Outperform and set a new price target of $58.00
Jefferies upgraded Ingevity from Hold to Buy and set a new price target of $62.00 from $52.00 previously
4 - Ingevity Corp (0001653477) (Issuer)
4 - Ingevity Corp (0001653477) (Issuer)
4 - Ingevity Corp (0001653477) (Issuer)